Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9285749 | 0.89 | ALDH1A1 (0.42) | CRHBPCRHR2HSD17B10ALDH1A1HPGD | |
| SCHEMBL11392792 | 0.89 | RORC (0.43) | CRHBPCRHR2ALDH1A1CYP3A4CYP3A5 | |
| SCHEMBL1758324 | 0.89 | CRHBP (0.48) | CRHBPCRHR2HSD17B10ALDH1A1HPGD | |
| SCHEMBL18073333 | 0.85 | LMNA (0.43) | CRHBPCRHR2HSD17B10ALDH1A1HPGD | |
| SCHEMBL24158366 | 0.85 | CYP19A1 (0.46) | CRHBPCRHR2ALDH1A1CYP2A6CYP3A4 | |
| SCHEMBL22114521 | 0.82 | KCNN4 (0.44) | ALDH1A1 | |
| SCHEMBL30444974 | 0.81 | CYP19A1 (0.47) | CRHBPCRHR2HSD17B10ALDH1A1HPGD | |
| SCHEMBL26753540 | 0.81 | CYP1A2 (0.43) | CYP1A2CYP3A4CYP3A5 | |
| SCHEMBL11591149 | 0.81 | CRHBP (0.53) | CRHBPCRHR2HSD17B10ALDH1A1HPGD | |
| SCHEMBL1191671 | 0.80 | CRHBP (0.35) | CRHBPCRHR2HSD17B10ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566033-B2 | Compound and an organic semiconducting layer comprising the same | NOVALED GMBH (DE) | 2023-01-31 | — | — | US | disclosed |
| US-20200339614-A1 | Compound and an Organic Semiconducting Layer Comprising the Same | NOVALED GMBH (DE) | 2020-10-29 | — | — | US | disclosed |
| US-7462405-B2 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY (US) | 2008-12-09 | — | — | US | disclosed |
| US-7462405-B2 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY (US) | 2008-12-09 | — | — | US | disclosed |
| US-20050136286-A1 | Organic element for electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC | 2005-06-23 | — | — | US | disclosed |
| US-20050123790-A1 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11566033-B2 | Compound and an organic semiconducting layer comprising the same | NR2E3, NR2C2, C1R | CRHBP 3449/4885CRHR2 224/4885HSD17B10 1449/4885 |
| US-20200339614-A1 | Compound and an Organic Semiconducting Layer Comprising the Same | NR2E3, C3AR1, C1R | CRHBP 3817/4885CRHR2 211/4885HSD17B10 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.